NPT-BEZ235, a dual inhibitor of PI3K and mTOR, increased ciliogenesis of VHL-deficient hTERT-PRE1 cells and reduced tumor burden in a mouse xenograft model of RCC. Here, VHL is linked to renal cell carcinoma.